In March 2021, Senators Portman (R-OH), Shelley Moore Capito (R-WV), Jeanne Shaheen (D-NH), and Joe Manchin (D-WV) introduced the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act. The legislation aims to help address barriers to non-opioid pain management for those enrolled in Medicare, which will help stem the opioid epidemic across the nation.
What does this mean for BioElectronics Corp? It means the future is now with Congressional approval.
Medical devices like the Recovery RX could receive "Medical Device Reimbursement: Reimbursement for qualifying devices would be similar to the amount paid by a hospital or ASC for a medical device under transitional “pass-through” status. This reimbursement would be implemented through the creation of new payment categories (APCs) for qualifying treatments"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
